Table 5.
Long-term follow-up results in 143 patients without, with incomplete and complete adjuvant chemotherapy after oncologic resection for pancreatic ductal adenocarcinoma.
| Adjuvant Chemotherapy |
||||
|---|---|---|---|---|
| None (n = 31) | Incomplete (n = 41) | Complete (n = 71) | p | |
| Deaths (total) | n = 28 (90%) | n = 33 (80%) | n = 53 (75%) | 0.1920 |
| Survivors | n = 3 (10%) | n = 8 (20%) | n = 18 (25%) | 0.1920 |
| Tumor recurrence | n = 23 (74%) | n = 34 (83%) | n = 59 (83%) | 0.5380 |
| Overall survivala | 13.8 (6–20) | 15.7 (12–18) | 22.6 (20–26) | 0.0225 |
| Disease free survivala | 8.5 (4–13) | 9.6 (7–12) | 13.3 (12–17) | 0.1219 |
a
Median survival time, 95% CI (months).